Identification of slpB, a cytotoxic protease from Serratia marcescens

Infection and Immunity

Volumn 83, Issue 7, 2015, Pages 2907-2916

  Shanks, Robert M Q ^a,b   Stella, Nicholas A ^a   Hunt, Kristin M ^a   Brothers, Kimberly M ^a   Zhang, Liang ^b   Thibodeau, Patrick H ^b  

^a University of Pittsburgh School of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOTOXIC FACTOR; PROTEINASE; PRTS PROTEIN; SLPB PROTEIN; SLPC PROTEIN; SLPD PROTEIN; UNCLASSIFIED DRUG; BACTERIAL TOXIN; PEPTIDE HYDROLASE; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENOME; BACTERIUM ISOLATE; BIOINFORMATICS; CANCER CELL LINE; CONJUNCTIVITIS; CORNEA CELL; CYTOTOXICITY; EPITHELIUM CELL; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATITIS; LUNG CARCINOMA; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SERRATIA MARCESCENS; TYPE I SECRETION SYSTEM; BACTERIAL EYE INFECTION; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; SERRATIA INFECTION;

BACTERIAL TOXINS; CELL LINE; CELL SURVIVAL; EPITHELIAL CELLS; EYE INFECTIONS, BACTERIAL; HUMANS; PEPTIDE HYDROLASES; SERRATIA INFECTIONS; SERRATIA MARCESCENS; VIRULENCE FACTORS;

EID: 84930989388     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.03096-14     Document Type: Article

References (62)

1. Cheng KH, Leung SL, Hoekman HW, Beekhuis WH, Mulder PG, Geerards AJ, Kijlstra A. 1999. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 354:181-185. http://dx .doi.org/10.1016/S0140-6736(98)09385-4.
2. Mah-Sadorra JH, Najjar DM, Rapuano CJ, Laibson PR, Cohen EJ. 2005. Serratia corneal ulcers: a retrospective clinical study. Cornea 24:793-800. http://dx.doi.org/10.1097/01.ico.0000159738.06167.88.
3. Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F. 2006. Microbial keratitis predisposing factors and morbidity. Ophthalmology 113:109-116. http://dx.doi.org/10.1016/j.ophtha.2005.08.013.
4. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 2000. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21:510-515. http://dx.doi.org/10 .1086/501795.
5. Mahlen SD. 2011. Serratia infections: from military experiments to current practice. Clin Microbiol Rev 24:755-791. http://dx.doi.org/10.1128 /CMR.00017-11.
6. Alexandrakis G, Alfonso EC, Miller D. 2000. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497-1502. http://dx.doi.org/10.1016/S0161-6420(00)00179-2.
7. Lavinsky F, Avni-Zauberman N, Barequet IS. 2013. Clinical characteristics and outcomes of patients admitted with presumed microbial keratitis to a tertiary medical center in Israel. Arq Bras Oftalmol 76:175-179. http://dx.doi.org/10.1590/S0004-27492013000300009.
8. Kowalski RP, Kowalski TA, Shanks RM, Romanowski EG, Karenchak LM, Mah FS. 2013. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection. Cornea 32:830-834. http://dx.doi.org/10.1097 /ICO.0b013e318268d6f4.
9. Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ. 1998. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 39:662-665.
10. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. 2005. Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci 46:2064-2070. http://dx.doi.org/10.1167/iovs.04 -0897.
11. Green SN, Sanders M, Moore QC, III, Norcross EW, Monds KS, Caballero AR, McDaniel LS, Robinson SA, Onwubiko C, O'Callaghan RJ, Marquart ME. 2008. Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest Ophthalmol Vis Sci 49:290-294. http://dx.doi.org/10.1167/iovs.07-0492.
12. Mun JJ, Tam C, Kowbel D, Hawgood S, Barnett MJ, Evans DJ, Fleiszig SM. 2009. Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun 77:2392-2398. http://dx.doi.org/10.1128/IAI.00173-09.
13. Matsumoto K. 2004. Role of bacterial proteases in pseudomonal and serratial keratitis. Biol Chem 385:1007-1016.
14. Marty KB, Williams CL, Guynn LJ, Benedik MJ, Blanke SR. 2002. Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens. Infect Immun 70:1121-1128. http://dx.doi.org/10.1128/IAI.70.3 .1121-1128.2002.
15. Molla A, Matsumoto K, Oyamada I, Katsuki T, Maeda H. 1986. Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture. Infect Immun 53:522-529.
16. Kreger AS, Griffin OK. 1975. Cornea-damaging proteases of Serratia marcescens. Invest Ophthalmol 14:190-198.
17. Lyerly D, Gray L, Kreger A. 1981. Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease. Infect Immun 33:927-932.
18. Miyagawa S, Matsumoto K, Kamata R, Okamura R, Maeda H. 1991. Spreading of Serratia marcescens in experimental keratitis and growth suppression by chicken egg white ovomacroglobulin. Jpn J Ophthalmol 35: 402-410.
19. Molla A, Oda T, Maeda H. 1987. Different binding kinetics of Serratia 56K protease with plasma alpha 2-macroglobulin and chicken egg white ovomacroglobulin. J Biochem 101:199-205.
20. Molla A, Kagimoto T, Maeda H. 1988. Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens. Infect Immun 56:916-920.
21. Kida Y, Inoue H, Shimizu T, Kuwano K. 2007. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor Infect Immun 75:164-174. http://dx.doi.org/10.1128/IAI.01239-06.
22. Butterworth MB, Zhang L, Heidrich EM, Myerburg MM, Thibodeau PH. 2012. Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. J Biol Chem 287:32556- 32565. http://dx.doi.org/10.1074/jbc.M112.369520.
23. Butterworth MB, Zhang L, Liu X, Shanks RM, Thibodeau PH. 2014. Modulation of the epithelial sodium channel (ENaC) by bacterial metalloproteases and protease inhibitors. PLoS One 9:e100313. http://dx.doi .org/10.1371/journal.pone.0100313.
24. Norqvist A, Norrman B, Wolf-Watz H. 1990. Identification and characterization of a zinc metalloprotease associated with invasion by the fish pathogen Vibrio anguillarum. Infect Immun 58:3731-3736.
25. Cowell BA, Twining SS, Hobden JA, Kwong MS, Fleiszig SM. 2003. Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 149:2291-2299. http://dx.doi.org/10.1099 /mic.0.26280-0.
26. Bozhokina ES, Tsaplina OA, Efremova TN, Kever LV, Demidyuk IV, Kostrov SV, Adam T, Komissarchik YY, Khaitlina SY. 2011. Bacterial invasion of eukaryotic cells can be mediated by actin-hydrolysing metalloproteases grimelysin and protealysin. Cell Biol Int 35:111-118. http://dx .doi.org/10.1042/CBI20100314.
27. Tonry JH, McNichol BA, Ramarao N, Chertow DS, Kim KS, Stibitz S, Schneewind O, Kashanchi F, Bailey CL, Popov S, Chung MC. 2012. Bacillus anthracis protease InhA regulates BslA-mediated adhesion in human endothelial cells. Cell Microbiol 14:1219-1230.
28. Hume EB, Conerly LL, Moreau JM, Cannon BM, Engel LS, Stroman DW, Hill JM, O'Callaghan RJ. 1999. Serratia marcescens keratitis: strainspecific corneal pathogenesis in rabbits. Curr Eye Res 19:525-532. http: //dx.doi.org/10.1076/ceyr.19.6.525.5283.
29. Pinna A, Usai D, Sechi LA, Carta A, Zanetti S. 2011. Detection of virulence factors in Serratia strains isolated from contact lens-associated corneal ulcers. Acta Ophthalmol 89:382-387. http://dx.doi.org/10.1111/j .1755-3768.2009.01689.x.
30. Matsumoto K, Maeda H, Takata K, Kamata R, Okamura R. 1984. Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958. J Bacteriol 157:225-232.
31. Létoffé S, Delepelaire P, Wandersman C. 1991. Cloning and expression in Escherichia coli of the Serratia marcescens metalloprotease gene: secretion of the protease from E. coli in the presence of the Erwinia chrysanthemi protease secretion functions. J Bacteriol 173:2160-2166.
32. Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62:293-300.
33. Miller VL, Mekalanos JJ. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170:2575.
34. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417- 1423.
35. Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF, Russo CL. 2003. Mucin gene expression in immortalized human conreal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 44:2496-2506. http://dx.doi.org/10.1167/iovs.02-0851.
36. Wingard JB, Romanowski EG, Kowalski RP, Mah FS, Ling Y, Bilonick RA, Shanks RM. 2011. A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. Antimicrob Agents Chemother 55:3788-3794. http://dx.doi.org/10.1128 /AAC.01828-10.
37. Shanks RM, Stella NA, Arena KE, Fender JE. 2013. Mutation of crp mediates Serratia marcescens serralysin and global secreted protein production. Res Microbiol 164:38-45. http://dx.doi.org/10.1016/j.resmic .2012.10.006.
38. Cruz-Romero M, Kelly AL, Kerry JP. 2008. Influence of packaging strategy on microbiological and biochemical changes in high-pressuretreated oysters. J Sci Food Agric 88:2713-2723. http://dx.doi.org/10.1002 /jsfa.3398.
39. Shanks RM, Kadouri DE, MacEachran DP, O'Toole GA. 2009. New yeast recombineering tools for bacteria. Plasmid 62:88-97. http://dx.doi .org/10.1016/j.plasmid.2009.05.002.
40. Shanks RM, Caiazza NC, Hinsa SM, Toutain CM, O'Toole GA. 2006. Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl Environ Microbiol 72:5027- 5036. http://dx.doi.org/10.1128/AEM.00682-06.
41. Shanks RM, Lahr RM, Stella NA, Arena KE, Brothers KM, Kwak DH, Liu X, Kalivoda EJ. 2013. A Serratia marcescens PigP homolog controls prodigiosin biosynthesis, swarming motility and hemolysis and is regulated by cAMP-CRP and HexS. PLoS One 8:e57634. http://dx.doi.org/10 .1371/journal.pone.0057634.
42. Zhang L, Conway JF, Thibodeau PH. 2012. Calcium-induced folding and stabilization of the Pseudomonas aeruginosa alkaline protease. J Biol Chem 287:4311-4322. http://dx.doi.org/10.1074/jbc.M111.310300.
43. Chung WC, Chen LL, Lo WS, Kuo PA, Tu J, Kuo CH. 2013. Complete genome sequence of Serratia marcescens WW4. Genome Announc 1(2): e0012613. http://dx.doi.org/10.1128/genomeA.00126-13.
44. Iguchi A, Nagaya Y, Pradel E, Ooka T, Ogura Y, Katsura K, Kurokawa K, Oshima K, Hattori M, Parkhill J, Sebaihia M, Coulthurst SJ, Gotoh N, Thomson NR, Ewbank JJ, Hayashi T. 2014. Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen. Genome Biol Evol 6:2096-2110. http://dx.doi.org/10 .1093/gbe/evu160.
45. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402. http: //dx.doi.org/10.1093/nar/25.17.3389.
46. Stöcker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W. 1995. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 4:823- 840.
47. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD. 2012. The Pfam protein families database. Nucleic Acids Res 40:D290-D301. http://dx.doi.org/10.1093 /nar/gkr1065.
48. Akatsuka H, Kawai E, Omori K, Shibatani T. 1995. The three genes lipB, lipC, and lipD involved in the extracellular secretion of the Serratia marcescens lipase which lacks an N-terminal signal peptide. J Bacteriol 177: 6381-6389.
49. Binet R, Letoffe S, Ghigo JM, Delepelaire P, Wandersman C. 1997. Protein secretion by Gram-negative bacterial ABC exporters-a review. Gene 192:7-11. http://dx.doi.org/10.1016/S0378-1119(96)00829-3.
50. Hege T, Feltzer RE, Gray RD, Baumann U. 2001. Crystal structure of a complex between Pseudomonas aeruginosa alkaline protease and its cognate inhibitor: inhibition by a zinc-NH2 coordinative bond. J Biol Chem 276:35087-35092. http://dx.doi.org/10.1074/jbc.M104020200.
51. Hoge R, Pelzer A, Rosenau F, Wilhelm S. 2010. Weapons of a pathogen: proteases and their role in virulence of Pseudomonas aeruginosa. Curr Res Technol Educ Top Appl Microbiol Microb Biotechnol 2:383-395. http: //www.formatex.info/microbiology2/383-395.pdf.
52. Miyajima S, Akaike T, Matsumoto K, Okamoto T, Yoshitake J, Hayashida K, Negi A, Maeda H. 2001. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 31:271-281. http://dx.doi.org/10.1006/mpat.2001 .0470.
53. Das S, Sheorey H, Taylor HR, Vajpayee RB. 2007. Association between cultures of contact lens and corneal scraping in contact lens related microbial keratitis. Arch Ophthalmol 125:1182-1185. http://dx.doi.org/10 .1001/archopht.125.9.1182.
54. Mayo MS, Schlitzer RL, Ward MA, Wilson LA, Ahearn DG. 1987. Association of Pseudomonas and Serratia corneal ulcers with use of contaminated solutions. J Clin Microbiol 25:1398-1400.
55. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. 2001. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 85:842-847. http://dx.doi.org/10.1136/bjo.85.7.842.
56. Verhelst D, Koppen C, Van Looveren J, Meheus A, Tassignon MJ. 2006. Contact lens-related corneal ulcers requiring hospitalization: a 7-year retrospective study in Belgium. Acta Ophthalmol Scand 84:522-526. http: //dx.doi.org/10.1111/j.1600-0420.2006.00681.x.
57. Holden BA, La Hood D, Grant T, Newton-Howes J, Baleriola-Lucas C, Willcox MD, Sweeney DF. 1996. Gram-negative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J 22:47-52.
58. Zhou R, Zhang R, Sun Y, Platt S, Szczotka-Flynn L, Pearlman E. 2012. Innate immune regulation of Serratia marcescens-induced corneal inflammation and infection. Invest Ophthalmol Vis Sci 53:7382-7388. http://dx .doi.org/10.1167/iovs.12-10238.
59. Ishii K, Adachi T, Hamamoto H, Sekimizu K. 2014. Serratia marcescens suppresses host cellular immunity via the production of an adhesioninhibitory factor against immunosurveillance cells. J Biol Chem 289: 5876-5888. http://dx.doi.org/10.1074/jbc.M113.544536.
60. Kalivoda EJ, Stella NA, Aston MA, Fender JE, Thompson PP, Kowalski RP, Shanks RM. 2010. Cyclic AMP negatively regulates prodigiosin production by Serratia marcescens. Res Microbiol 161:158-167. http://dx.doi .org/10.1016/j.resmic.2009.12.004.
61. Kadouri DE, Shanks RM. 2013. Identification of a methicillin-resistant Staphylococcus aureus inhibitory compound isolated from Serratia marcescens. Res Microbiol 164:821-826. http://dx.doi.org/10.1016/j.resmic .2013.06.002.
62. Kalivoda EJ, Horzempa J, Stella NA, Sadaf A, Kowalski RP, Nau GJ, Shanks RM. 2011. New vector tools with a hygromycin resistance marker for use with opportunistic pathogens. Mol Biotechnol 48:7-14. http://dx .doi.org/10.1007/s12033-010-9342-x.